logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8912139 B1

PDFFull Text
Date of Patent:
Dec. 16, 2014

Filed:

Mar. 31, 2014

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

Yulia A. Komarova, Chicago, IL (US);

Uzma Saqib, Chicago, IL (US);

Stephen M. Vogel, Chicago, IL (US);

Asrar B. Malik, Chicago, IL (US);

Assignee:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Attorneys:

Polsinelli PC

Teddy C. Scott, Jr.

Ron Galant

Primary Examiner:

James H Alstrum Acevedo

Assistant Examiner:

Tara Martinez

Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 7/08 (2006.01); C07K 7/06 (2006.01); C07K 14/705 (2006.01); A61K 47/48 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48276 (2013.01); A61K 38/1709 (2013.01); A61K 38/00 (2013.01); C07K 7/08 (2013.01); C07K 7/06 (2013.01); C07K 2319/033 (2013.01); C07K 14/705 (2013.01); C07K 2319/10 (2013.01);
Abstract

Provided herein are peptide inhibitors of the interaction between End Binding Protein 3 (EB3) and Inositol 1,4,5-Trisphosphate Receptor Type 3 (IP3R3). Also provided are methods and materials for treating lung injury, including acute lung injury, which may include hyperpermeability of lung vessels, vascular leakage, the development of edema, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion.

Find Patent Forward Citations

Komarova, Yulia. (2014). Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion (U.S. Patent No. 8912139). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8912139

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…